Valuation: G MEDPAR

Market Cap 723K 635K 591K 542K 1.02M 69.62M 1.03M 7.01M 2.74M 34.23M 2.71M 2.66M 118M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.21M 2.06M 1.89M 3.55M 243M 3.6M 24.44M 9.55M 119M 9.46M 9.26M 413M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.36
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/3/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
31/3/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.44M 4.13M 3.79M 7.12M 487M 7.23M 49.06M 19.17M 239M 18.99M 18.58M 828M 4.42M 3.88M 3.61M 3.31M 6.22M 426M 6.32M 42.87M 16.75M 209M 16.59M 16.24M 724M
Net income -14.76M -12.96M -12.05M -11.06M -20.78M -1.42B -21.1M -143M -55.92M -699M -55.4M -54.21M -2.42B -13.52M -11.88M -11.04M -10.13M -19.04M -1.3B -19.34M -131M -51.24M -640M -50.76M -49.66M -2.21B
Net Debt 2.41M 2.11M 1.97M 1.8M 3.39M 232M 3.44M 23.36M 9.12M 114M 9.04M 8.84M 394M 1.8M 1.58M 1.47M 1.35M 2.53M 173M 2.57M 17.43M 6.81M 85.08M 6.75M 6.6M 294M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock